A carregar...
A Nationwide Study on the Incidence of Breast Cancer in Korean Women with Osteoporosis Receiving Raloxifene Treatment
PURPOSE: Raloxifene is a selective estrogen receptor modulator (SERM), and raloxifene treatment for osteoporosis is reimbursable under the Korean National Health Insurance. Evidence suggests that SERMs use reduces the risk of breast cancer in Asian population. Herein, we retrospectively investigated...
Na minha lista:
| Publicado no: | J Breast Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Breast Cancer Society
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8250100/ https://ncbi.nlm.nih.gov/pubmed/34128366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2021.24.e28 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|